These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20370621)

  • 61. Anti-virulence potential of eugenyl acetate against pathogenic bacteria of medical importance.
    Musthafa KS; Voravuthikunchai SP
    Antonie Van Leeuwenhoek; 2015 Mar; 107(3):703-10. PubMed ID: 25613850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular HtrA serine proteases: An emerging new strategy in bacterial pathogenesis.
    Backert S; Bernegger S; Skórko-Glonek J; Wessler S
    Cell Microbiol; 2018 Jun; 20(6):e12845. PubMed ID: 29582532
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria.
    Pagès JM; James CE; Winterhalter M
    Nat Rev Microbiol; 2008 Dec; 6(12):893-903. PubMed ID: 18997824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections.
    Dohmen PM
    J Hosp Infect; 2008 Nov; 70 Suppl 2():15-20. PubMed ID: 19022117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clocks and switches: bacterial gene regulation by DNA adenine methylation.
    Low DA; Casadesús J
    Curr Opin Microbiol; 2008 Apr; 11(2):106-12. PubMed ID: 18396448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacterial effector interplay: a new way to view effector function.
    Shames SR; Finlay BB
    Trends Microbiol; 2012 May; 20(5):214-9. PubMed ID: 22425230
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microbial epidemiology patterns of surgical infection pathogens.
    Debbia EA; Schito GC; Gualco L; Tonoli E; Dolcino M; Marchese A
    J Chemother; 2001 Nov; 13 Spec No 1(1):84-8. PubMed ID: 11936386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of type III secretion genes as a general indicator of bacterial virulence.
    Stuber K; Frey J; Burnens AP; Kuhnert P
    Mol Cell Probes; 2003 Feb; 17(1):25-32. PubMed ID: 12628591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type IV secretion systems in pathogenic bacteria.
    Fischer W; Haas R; Odenbreit S
    Int J Med Microbiol; 2002 Sep; 292(3-4):159-68. PubMed ID: 12398207
    [No Abstract]   [Full Text] [Related]  

  • 70.
    Purnapatre KP; Rao M; Pandya M; Khanna A; Chaira T; Bambal R; Upadhyay DJ; Masuda N
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expanded Gram-Negative Antimicrobial Prophylaxis Reduces Surgical Site Infections in Hip Arthroplasty.
    Bosco JA; Prince Rainier R Tejada ; Catanzano AJ; Stachel AG; Phillips MS
    J Arthroplasty; 2016 Mar; 31(3):616-21. PubMed ID: 26521131
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The tad locus: postcards from the widespread colonization island.
    Tomich M; Planet PJ; Figurski DH
    Nat Rev Microbiol; 2007 May; 5(5):363-75. PubMed ID: 17435791
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extracellular proteases and possible disease related virulence mechanisms of two marine bacteria implicated in an opportunistic bacterial infection of Nephrops norvegicus.
    Ridgway ID; Small HJ; Atkinson RJ; Birkbeck HT; Taylor AC; Neil DM
    J Invertebr Pathol; 2008 Sep; 99(1):14-9. PubMed ID: 18617185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunoglobulin A protease is a virulence factor for gram-negative pneumonia.
    Diebel LN; Liberati DM; Baylor AE; Brown WJ; Devlin J
    Surgery; 2004 Oct; 136(4):937-43. PubMed ID: 15467681
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overcoming multidrug resistance in gram-negative bacteria.
    Poole K
    Curr Opin Investig Drugs; 2003 Feb; 4(2):128-39. PubMed ID: 12669372
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents.
    Smith RP; Paxman JJ; Scanlon MJ; Heras B
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Introduction: microbial disease: recent studies show that novel extracellular components can enhance microbial resistance to lethal host chemicals and increase virulence.
    Rowbury RJ
    Sci Prog; 2002; 85(Pt 1):1-11. PubMed ID: 11969116
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial: Research implications on microbial virulence factors, resistance, and new therapeutic strategies in the context of future infectious disease therapies.
    Dyląg M; Filipić B; Augustyniak D; Milenković MT
    Front Cell Infect Microbiol; 2024; 14():1406119. PubMed ID: 38912209
    [No Abstract]   [Full Text] [Related]  

  • 80. Cell-cell communication in Gram-negative bacteria.
    Welch M; Mikkelsen H; Swatton JE; Smith D; Thomas GL; Glansdorp FG; Spring DR
    Mol Biosyst; 2005 Sep; 1(3):196-202. PubMed ID: 16880983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.